These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2143745)

  • 1. [Luteinizing hormone-releasing hormone agonists for treatment of breast cancer].
    Gez E; Kovner F
    Harefuah; 1990 Jun; 118(11):655-8. PubMed ID: 2143745
    [No Abstract]   [Full Text] [Related]  

  • 2. [LHRH analogs--new possibilities in the treatment of prostatic cancer].
    Baranowska B
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):1009-12. PubMed ID: 6239145
    [No Abstract]   [Full Text] [Related]  

  • 3. [Zoladex in prostatic carcinoma].
    Di Silverio F; Serio M
    Drugs Exp Clin Res; 1990; 16 Suppl():19-29. PubMed ID: 2150501
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormone therapy of metastatic breast carcinoma].
    Höffken K; Miller AA; Miller B; Becher R; Schmidt CG
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1799-802. PubMed ID: 3933941
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of carcinoma of the prostate with analogs of LHRH].
    Rubio Herrera MA; Calle Fernández JR
    Rev Clin Esp; 1986 Nov; 179(8):407-11. PubMed ID: 2951782
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gn-RH analogs and benign prostatic hypertrophy].
    Forti G; Serio M
    Drugs Exp Clin Res; 1990; 16 Suppl():31-2. PubMed ID: 1706977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Luteinizing hormone-releasing hormone agonists for treatment of prostatic cancer].
    Gez E
    Harefuah; 1990 Apr; 118(8):483-6. PubMed ID: 2192959
    [No Abstract]   [Full Text] [Related]  

  • 8. [Zoladex in the treatment of mammary carcinoma].
    Sismondi P; Giai M; Defabiani E; Cortese P
    Drugs Exp Clin Res; 1990; 16 Suppl():47-58. PubMed ID: 2150503
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment with different GnRH analogues in women: preliminary evidence for disparant effects on serum androgen concentrations.
    Rossmanith WG; Wirth U; Sasse V; Lauritzen C
    Horm Metab Res; 1991 Apr; 23(4):198-9. PubMed ID: 1831437
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment with an LHRH analogue in patients with advanced pancreatic cancer. A preliminary report.
    Andrén-Sandberg A
    Acta Chir Scand; 1990 Aug; 156(8):549-51. PubMed ID: 2146849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma.
    Chodak GW
    Urology; 1989 May; 33(5 Suppl):42-4. PubMed ID: 2523610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancer.
    Nicholson RI; Walker KJ
    Chemioterapia; 1985 Jun; 4(3):249-51. PubMed ID: 3161643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential effects of GnRH analogs on androgen concentrations in females].
    Wirth U; Rossmanith WG; Sasse V; Lauritzen C
    Gynakol Rundsch; 1991; 31 Suppl 2():400-2. PubMed ID: 1838737
    [No Abstract]   [Full Text] [Related]  

  • 14. Monthly implant of luteinizing hormone-releasing hormone agonist: a practical therapeutic approach for sex-steroid dependent gynecologic diseases.
    Lemay A
    Fertil Steril; 1987 Jul; 48(1):10-2. PubMed ID: 2954859
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of cancer of the prostate. Role of gonadorelin analogs].
    Steg A
    Presse Med; 1989 May; 18(20):1007-9. PubMed ID: 2524792
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacology and possibilities for use of gonadotropin releasing hormone analogs].
    Breckwoldt M; Zahradnik HP; Karck U
    Gynakologe; 1992 Aug; 25(4):241-6. PubMed ID: 1398253
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent development of endocrine treatment for breast cancer--new drugs and new treatment methods using tamoxifen].
    Sonoo H; Kurebayashi J
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2289-99. PubMed ID: 8259841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
    Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
    Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis.
    Rossi GA; Balbi B; Oddera S; Lantero S; Ravazzoni C
    Am Rev Respir Dis; 1991 Jan; 143(1):174-6. PubMed ID: 1824744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale in use of LHRH analogues in endometriosis.
    Shaw RW
    Horm Res; 1989; 32 Suppl 1():110-4. PubMed ID: 2533143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.